Decreased Susceptibility to Ciprofloxacin inSalmonella entericaserotype Typhi, United Kingdom
Open Access
- 1 June 2001
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 7 (3) , 448-450
- https://doi.org/10.3201/eid0703.010315
Abstract
In 1999, 23% of Salmonella enterica serotype Typhi isolates from patients in the United Kingdom exhibited decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/L); more than half were also resistant to chloramphenicol, ampicillin, and trimethoprim. Increasing numbers of treatment failures have been noted. Most infections have been in patients with a recent history of travel to India and Pakistan.Keywords
This publication has 10 references indexed in Scilit:
- Ciprofloxacin-resistant Salmonella typhi and treatment failureThe Lancet, 1999
- Molecular Fingerprinting of Multidrug-Resistant Salmonella enterica Serotype TyphiEmerging Infectious Diseases, 1998
- Quinolone-resistant Salmonella typhi in VietnamThe Lancet, 1998
- Epidemic ciprofloxacin-resistant Salmonella typhi in TajikistanThe Lancet, 1998
- Multidrug-Resistant Salmonella typhi: A Worldwide EpidemicClinical Infectious Diseases, 1997
- Treatment of multiresistant typhoid feverThe Lancet, 1991
- Spread of multiresistant Salmonella typhlThe Lancet, 1990
- Does chloramphenicol remain the drug of choice for typhoid?Epidemiology and Infection, 1987
- Transferable Chloramphenicol Resistance in Salmonella typhiNature, 1972
- Chloramphenicol Resistance in the Typhoid BacillusBMJ, 1972